Karin Conde-Knape Email & Phone Number
Chief Scientific Officer @ Valo
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Karin Conde-Knape Location
- United States
Karin Conde-Knape Work
- Board Member @ Keystone’s symposia (June 2026 - Present)
- Chief Scientific Officer @ (May 2026 - Present)
- Senior Vice President Early Development @ (March 2025 - October 2025)
- Senior Vice President Global Drug Discovery @ (March 2021 - March 2025)
- Corporate Vice President Diabetes, Cardio-renal and Translational Research @ (January 2020 - March 2021)
- Corporate Vice President Cardiovascular and Liver Diseases @ (January 2018 - January 2020)
- Vice President Cardiovascular and Metabolism @ Johnson and Johnson Medical (September 2013 - December 2017)
- Acting Head of Discovery @ (September 2012 - August 2013)
- Research Director, Head of In vivo Pharmacology @ (April 2010 - August 2013)
Karin Conde-Knape Education
- Columbia University Vagelos College of Physicians and Surgeons
Post-doc (Lipids and Lipoproteins)
1998-2002 - University of Connecticut 1997-1998
Karin Conde-Knape Skills
- Leadership
- Project Leader
- Cardiovascular Disease
- Clinical Trials
- Drug Design
- Type 2 Diabetes
- Metabolism
- Translational Medicine
- CRO
- In Vivo
- Drug Product
- Target Identification
- In Vivo Models For Kidney Disease
- Networking
- Clinical Research
- Data Analysis
- Biotechnology
- Immunology
- Life Sciences
- Team Leadership
- Validation
- Atherosclerosis
- Quality Assurance
- Drug Discovery
- Oncology
- Microsoft Excel
- Drug Development
- Cross Functional Team Leadership
- In Vivo Models For Metabolic Diseases
- Drug Discover
- Change Management
- Clinical Development
- In Vitro
- Training
- Customer Service
- Diabetes
- Pharmacology
- Business Strategy
- Management
- Project Management
- Product Development
- Research
- Pharmaceutical Industry
- Diabetic Nephropathy
- Chronic Kidney Disease
- Dyslipidemia
- Biomarkers
- Cardiiovascular
- Biomarker Discovery
- Kidney Disease
- Management Of Collaborations
- Sales
- Microsoft Office
- Marketing
- Business Development
Karin Conde-Knape Summary
- Karin Conde-Knape, based in United States, is currently a Chief Scientific Officer at Valo Health. Karin Conde-Knape brings experience from previous roles at Keystone’s symposia and Novo Nordisk. Karin Conde-Knape holds a 1998 - 2002 Post-doc in Lipids and Lipoproteins @ Columbia University Vagelos College of Physicians and Surgeons. With a robust skill set that includes Leadership, Project Leader, Cardiovascular Disease, Clinical Trials, Drug Design and more. Karin Conde-Knape has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Karin Conde-Knape?
Find contact details for 700 million professionals.
Top Valo Employees
Virginie Buggia-Prevot
Executive Director, Drug Discovery
Boston, MA, US
Alex Greenfield
Head of Translational Platform Engineering
New York, NY, US
Rita Kale
Chief Financial Officer
New York, NY, US
Rachel Flach
Vice President, Head of Biology
Cambridge, MA, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co